First Author: D.Beselga PORTUGAL
Co Author(s): A. Campos M. Castro J. Castro Sousa C. Fernandes F. Carvalheira D. Castanheira
Purpose:
To present the results of the incidence of postcataract surgery endophthalmitis after and before the introduction of the European Society of Cataract and Refractive Surgeons (ESCRS) protocol in 2007 in our department.
Setting:
Ophthalmology Department, Hospital Center Leiria-Pombal, Portugal.
Methods:
Retrospective unicentric study of 15689 eyes submitted to cataract surgery between 2005 and 2011. Surgeries were performed by different surgeons. After June 2007 the ESCRS protocol was introduced and all patients were submitted to intra-camerular injection of 0.1 ml of Cefuroxime (10mg/ml) at the end of cataract surgery. Cefuroxime was prepared prior to surgery in the operating room. All patients were observed between 6 weeks and 3 months after surgery.
Results:
Between January 2005 and June 2007, before the introduction of the ESCRS protocol in our department, a total of 2299 patients were submitted to cataract surgery and there were ten cases of postoperative endophthalmitis (0.14%). After the introduction of the protocol 13,390 surgeries were performed and there were no cases of endophthalmitis.
Conclusions:
Post-operative endophthalmitis remains one of the most devastating cataract surgery complications so it is an important issue to be prevented. The ESCRS endophthalmitis study demonstrated a near 5-fold decrease in the rate of postoperative endophthalmitis with the use of intra-camerular cefuroxime during cataract surgery. Our results also provide strong evidence of the usefulness of peroperative cefuroxime as prophylactic of post-operative endophthalmitis. FINANCIAL DISCLOSURE?: No
Please wait while information is loading.
